CXCL8 and non-small cell lung carcinoma: Of its reported actions, IL-8 has been linked to the recruitment and activation of MDSCs, neutrophils, and other myeloid cell populations to the tumor microenvironment, and the serum concentration of IL-8 is predictive of responses to immunotherapies in melanoma and non-small-cell lung cancer (17, 18).